Arrowhead Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	-37.97	30.11	-609.69	-209.28	-176.49	-140.85
Depreciation & Amortization	24.66	23.93	18.6	12.49	10.42	8.27
Stock-Based Compensation	67.12	63.37	73.97	78.13	120.89	76.67
Other Adjustments	88.92	83.47	27.99	16.31	7.34	-1.44
Change in Receivables	-266.51	-56.97	-	1.41	8.85	-9.41
Changes in Accounts Payable	22.41	6.29	-5.54	33	-6.59	2.63
Changes in Accrued Expenses	18.54	41.5	32.12	-14.97	17.75	9.52
Changes in Unearned Revenue	165.76	2.4	-0.87	-129.18	-112.5	223.26
Changes in Other Operating Activities	-25.52	-14.54	0.58	58.19	-5.8	2.66
Operating Cash Flow	339.31	179.55	-462.85	-153.89	-136.13	171.31
Capital Expenditures	-17.3	-22.67	-141.47	-176.74	-52.78	-23.57
Purchases of Investments	-899.44	-796.26	-720.95	-246.14	-223.39	-240.7
Proceeds from Sale of Investments	686.79	689.63	442.34	326.72	270.75	122.59
Investing Cash Flow	-229.95	-129.29	-420.07	-96.16	-5.42	-141.68
Long-Term Debt Issued	3.16	10.26	392	-	-	-
Long-Term Debt Repaid	-293.31	-201.63	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-290.14	-191.37	392	-	-	-
Issuance of Common Stock	188.47	270.37	431.65	3.05	5.19	11.31
Net Common Stock Issued (Repurchased)	188.47	270.37	431.65	3.05	5.19	11.31
Other Financing Activities	-2.5	-5	46.87	250	60	-
Financing Cash Flow	38.62	74.01	870.52	253.05	65.19	11.31
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.23	-0.4	4.2	-0.12	-0.07	-0.09
Net Cash Flow	147.98	124.26	-12.4	3.01	-76.36	40.94
Free Cash Flow	322.01	156.89	-604.32	-330.63	-188.91	147.75
Free Cash Flow Growth	105.25%	-	-	-	-	-
FCF Margin	29.52%	18.91%	-17018.30%	-137.34%	-77.67%	106.84%
Free Cash Flow Per Share	2.35	1.17	-5.05	-3.10	-1.79	1.42
Levered Free Cash Flow	100.67	-156.1	-304.08	-422.48	-325.56	81.92
Unlevered Free Cash Flow	463.95	94.37	-694.95	-424.97	-331.91	73.73

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.